C. Ferri

发表

Prion protein gene polymorphism and Alzheimer's disease: one modulatory trait of cognitive decline?

M. Franceschi, C. Mariani, F. Licastro, 2001, Journal of neurology, neurosurgery, and psychiatry.

Lack of Sterol Regulatory E lement Binding Factor-1 c Imposes Glial Fatty Acid Utilization Leading to Peripheral Neuropathy Graphical

G. Cavaletti, L. Garcia-Segura, Í. Azcoitia, 2015 .

Treatment with IFB-088 Improves Neuropathy in CMT1A and CMT1B Mice

F. Baas, Yunhong Bai, M. Shy, 2021, Molecular Neurobiology.

Enhanced axonal Neuregulin-1 type-III signaling ameliorates disease severity in a CMT1B mouse model

K. Nave, L. Wrabetz, N. Mitro, 2018, bioRxiv.

Laminin 211 inhibits protein kinase A in Schwann cells to modulate neuregulin 1 type III-driven myelination

K. Nave, L. Wrabetz, K. Monk, 2017, PLoS biology.

Phosphorylation of eIF2α Promotes Schwann Cell Differentiation and Myelination in CMT1B Mice with Activated UPR

R. Kaufman, L. Wrabetz, M. D'Antonio, 2020, The Journal of Neuroscience.

Lack of association betweenIL-1A and IL-1Bpromoter polymorphisms and multiple sclerosis

G. Comi, G. Magnani, L. Grimaldi, 2000, Journal of neurology, neurosurgery, and psychiatry.

IL-1 genes in myasthenia gravis: IL-1A −889 polymorphism associated with sex and age of disease onset

L. Grimaldi, F. Veglia, R. Mantegazza, 2002, Journal of Neuroimmunology.

APOE −491 promoter polymorphism is a risk factor for late-onset Alzheimer’s disease

M. Franceschi, S. Sorbi, C. Mariani, 1999, Neurology.

Electron Microscopy for the Analysis of Peripheral Nerve Myelin.

A. Quattrini, M. D'Antonio, C. Ferri, 2018, Methods in molecular biology.

Enhanced axonal neuregulin-1 type-III signaling ameliorates neurophysiology and hypomyelination in a Charcot–Marie–Tooth type 1B mouse model

K. Nave, L. Wrabetz, N. Mitro, 2018, Human molecular genetics.

MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B.

D. Kirschner, M. Pennuto, Xingyao Wu, 2012, Brain : a journal of neurology.

MpzR 98 C arrests Schwann cell development in a mouse model of early-onset Charcot – Marie – Tooth disease type 1 B

D. Kirschner, M. Pennuto, Xingyao Wu, 2012 .

Interleukin-1B polymorphism is associated with age at onset of Alzheimer’s disease

M. Franceschi, S. Sorbi, C. Mariani, 2003, Neurobiology of Aging.

Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients

V. Martinelli, G. Comi, G. Comi, 1999, Neurology.

A new mouse model of Charcot-Marie-Tooth 2J neuropathy replicates human axonopathy and suggest alteration in axo-glia communication

E. R. Wilson, G. Kidd, D. Ding, 2022, PLoS genetics.

A Photoprotein in Mouse Embryonic Stem Cells Measures Ca2+ Mobilization in Cells and in Animals

L. Wrabetz, L. Piemonti, A. Menegon, 2010, PloS one.

Association of early‐onset Alzheimer's disease with an interleukin‐1α gene polymorphism

M. Franceschi, S. Sorbi, C. Mariani, 2000, Annals of neurology.

Lack of sterol regulatory element binding factor-1c imposes glial Fatty Acid utilization leading to peripheral neuropathy.

G. Cavaletti, L. Garcia-Segura, Í. Azcoitia, 2015, Cell metabolism.

Schwann cells ER-associated degradation contributes to myelin maintenance in adult nerves and limits demyelination in CMT1B mice

M. Molinari, L. Wrabetz, F. Bianchi, 2019, PLoS genetics.

Perlecan is recruited by dystroglycan to nodes of Ranvier and binds the clustering molecule gliomedin

E. Peles, L. Wrabetz, R. Soininen, 2015, The Journal of cell biology.

Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?

G. Annoni, F. Licastro, L. Grimaldi, 2000, Journal of Neuroimmunology.

Regulation of cholesterol/lipid biosynthetic genes by Egr2/Krox20 during peripheral nerve myelination

J. Svaren, L. Wrabetz, R. Srinivasan, 2005, Journal of neurochemistry.

Sustained Expression of Negative Regulators of Myelination Protects Schwann Cells from Dysmyelination in a Charcot–Marie–Tooth 1B Mouse Model

L. Wrabetz, M. Feltri, C. Scapin, 2018, The Journal of Neuroscience.

APOE ε2-4 and -491 polymorphisms are not associated with MS

G. Comi, L. Grimaldi, F. Veglia, 1999, Neurology.

Gene polymorphism affecting α1‐antichymotrypsin and interleukin‐1 plasma levels increases Alzheimer's disease risk

G. Annoni, F. Licastro, F. Veglia, 2000, Annals of neurology.

Apolipoprotein E and α-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease

G. Annoni, F. Licastro, L. Grimaldi, 1999, Neuroscience Letters.

Adenosine A2A Receptors and Neuroprotection

E. Ongini, R. Bertorelli, C. Ferri, 1997, Annals of the New York Academy of Sciences.

Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease.

G. Annoni, F. Licastro, L. Grimaldi, 1999, Neuroscience Letters.

APOE epsilon2-4 and -491 polymorphisms are not associated with MS.

G. Comi, L. Grimaldi, F. Veglia, 1999, Neurology.

A novel mouse model of CMT1B identifies hyperglycosylation as a new pathogenetic mechanism

J. Svaren, A. Schenone, L. Nobbio, 2022, Human molecular genetics.

P0S63del impedes the arrival of wild-type P0 glycoprotein to myelin in CMT1B mice.

L. Wrabetz, A. Messing, P. Fratta, 2009, Human molecular genetics.

P 0 S 63 del impedes the arrival of wild-type P 0 glycoprotein to myelin in CMT 1 B mice

L. Wrabetz, A. Messing, P. Fratta, 2011 .

Lack of sterol regulatory element binding factor-1c imposes glial Fatty Acid utilization leading to peripheral neuropathy.

G. Cavaletti, L. Garcia-Segura, Í. Azcoitia, 2015, Cell metabolism.

Association study of a new polymorphism in the PECAM-1 gene in multiple sclerosis

G. Comi, L. Grimaldi, B. Colombo, 2000, Journal of Neuroimmunology.